Fate Therapeutics (FATE) Short term Debt (2016 - 2019)
Historic Short term Debt for Fate Therapeutics (FATE) over the last 8 years, with Q3 2019 value amounting to $13.9 million.
- Fate Therapeutics' Short term Debt rose 32683.82% to $13.9 million in Q3 2019 from the same period last year, while for Sep 2019 it was $13.9 million, marking a year-over-year increase of 32683.82%. This contributed to the annual value of $2.4 million for FY2018, which is N/A changed from last year.
- Fate Therapeutics' Short term Debt amounted to $13.9 million in Q3 2019, which was up 32683.82% from $5.4 million recorded in Q2 2019.
- In the past 5 years, Fate Therapeutics' Short term Debt ranged from a high of $13.9 million in Q3 2019 and a low of $758000.0 during Q1 2018
- For the 5-year period, Fate Therapeutics' Short term Debt averaged around $5.9 million, with its median value being $6.0 million (2015).
- In the last 5 years, Fate Therapeutics' Short term Debt skyrocketed by 96284.78% in 2015 and then plummeted by 9011.86% in 2018.
- Fate Therapeutics' Short term Debt (Quarter) stood at $7.7 million in 2015, then increased by 6.48% to $8.2 million in 2016, then dropped by 6.3% to $7.7 million in 2017, then crashed by 68.22% to $2.4 million in 2018, then soared by 471.45% to $13.9 million in 2019.
- Its Short term Debt was $13.9 million in Q3 2019, compared to $5.4 million in Q2 2019 and $3.9 million in Q1 2019.